BioUtah

Utah is heading to San Diego! 🧬

BioUtah and our life sciences partners are taking center stage at the Utah Pavilion during the BIO International Convention, June 22–25 in San Diego, CA.

We're proud to co-host alongside the Governor's Office of Economic Development, Nucleus Institute, University of Utah Technology Licensing Office, World Trade Center Utah, Utah Inland Port Authority, The Point Utah, Salt Lake City Department of Economic Development, and the Economic Development Corporation of Utah.

Together, we're showcasing the innovation, collaboration, and patient-focused breakthroughs that make Utah one of the nation's fastest-growing life sciences hubs.

📍 Attending BIO 2026? Stop by the Utah Pavilion (Booth #5635) and connect with us.

🎉 BioUtah Welcomes New Member nCAP Medical! 🎉

nCAP Medical is advancing a portfolio of breakthrough general wellness and medical devices—soon to include next-generation diagnostic technologies—all powered by its proprietary Neuro Capacitive Technology. This platform positions nCAP Medical at the intersection of pain management, neural modulation, and non-invasive physiological sensing. 🚀

More 👉 https://ow.ly/RP9p50Z88TL

Rep. Kennedy Supports Efforts to Address Global Drug Pricing Imbalances 🏛️

Rep. Mike Kennedy (R-UT) has joined colleagues in urging U.S. Trade Rep. Jamieson Greer to address foreign pricing policies and trade practices that raise drug costs for Americans. 📄

BioUtah appreciates Rep. Kennedy’s support for policies that promote innovation, strengthen competitiveness, and help ensure continued investment in life-saving therapies. 🧬

More 👉 https://ow.ly/cfwR50Z88Ml

SINTX Technologies Announces $5.0M Capital Raise 💼

SINTX Technologies has secured approximately $5.0M in gross proceeds, including a $4.5M private placement priced at the market under Nasdaq rules. The financing will support the company’s continued growth and strategic initiatives. 📈

Congratulations to the SINTX team on this important funding milestone! 🚀

More 👉 https://ow.ly/v5WF50Z88x9

🧬 Ratio Therapeutics & PharmaLogic Expand Manufacturing Collaboration

Ratio Therapeutics & PharmaLogic have expanded their manufacturing partnership to support increased clinical supply of [Ac-225]RTX-2358, Ratio’s FAP-targeted therapeutic. Under the agreement, manufacturing capacity will grow through PharmaLogic’s Idaho Falls therapeutics facility. ⚙️

A significant step forward in advancing innovative radiotherapeutic treatments and supporting future growth. 🚀

More 👉 https://ow.ly/5muu50Z88qI

nView Medical Surpasses 1,000 Surgeries 🎉

🏥 A major milestone for nView medical as the company surpasses 1,000 surgeries utilizing its intraoperative 3D imaging and navigation technology. This achievement reflects growing clinical adoption and the impact of advanced imaging solutions in the operating room.

👏 Congratulations to the nView team on this exciting accomplishment and continued momentum! 🚀

More 👉 https://ow.ly/hTge50Z88aQ

BioUtah Members Save BIG with ALT! 🔬

🧪 ALT helps BioUtah member companies afford premium lab equipment with certified refurbished instruments at guaranteed discounts—and turn idle equipment into cash or credit through trade‑ins, consignment, and auctions.

Start Saving 👉 https://ow.ly/PjiZ50Z6ke6

📣 The 2026 Biosphere Magazine Media Kit Is Here! 📣

📖 Put your company in front of Utah’s leading life sciences executives, innovators, investors, and decision-makers through BioUtah’s premier annual publication. Distributed in partnership with Utah Business, Biosphere reaches more than 10,500 targeted recipients and a readership exceeding 50,000 people statewide. 🧬

Don't miss the opportunity to elevate your brand and tell your story to Utah’s life sciences community—explore advertising opportunities today! 🚀

More 👉 https://ow.ly/Eqo050Z6kLG

👏 NanoKar Therapeutics Appoints Craig Mosman as CEO

NanoKar Therapeutics has formally appointed Craig Mosman, JD, as Chief Executive Officer. In his new role, Mosman will lead the company’s partnership strategy and translational data initiatives as NanoKar advances pioneering research from the University of Utah toward a partner-ready cell therapy platform. 🧬

Congratulations to Craig and the NanoKar team on this exciting leadership milestone and the journey ahead! 🚀

More 👉 https://ow.ly/gj4h50Z6kuR

🏆 Fluidx Earns “Best of GEST” Recognition

Congratulations to Fluidx for receiving 2nd Place in the "Best of GEST" Awards at the recent Global Embolization Symposium & Technologies (GEST) conference. The recognition was awarded for the company’s abstract, “Results from the GPX IDE Pivotal Clinical Trial (Evaluation of a Simple-Prep Controlled Embolic).” 🎉

🚀 A well-deserved honor that highlights the innovative work being done to advance patient care and interventional medicine!

More 👉 https://ow.ly/XoCQ50Z6kmA